Book contents
- Opioid-Use Disorders in Pregnancy
- Opioid-Use Disorders in Pregnancy
- Copyright page
- Contents
- Contributors
- Preface and Acknowledgments
- Section 1 Substance Use Disorders in Women and Pregnancy
- Section 2 Antepartum and Intrapartum Care
- Chapter 9 Prenatal Care in Substance-Using Pregnant Women
- Chapter 10 Treatment Approaches in Women with Substance Use Disorders Who Become Pregnant
- Chapter 11 Medication Assisted Treatment for Opioid Use Disorder during Pregnancy
- Chapter 12 Labor and Delivery Management in Women with Substance Use Disorder
- Section 3 Postpartum
- Section 4 The Newborn
- Index
- References
Chapter 9 - Prenatal Care in Substance-Using Pregnant Women
from Section 2 - Antepartum and Intrapartum Care
Published online by Cambridge University Press: 08 June 2018
Edited by
Book contents
- Opioid-Use Disorders in Pregnancy
- Opioid-Use Disorders in Pregnancy
- Copyright page
- Contents
- Contributors
- Preface and Acknowledgments
- Section 1 Substance Use Disorders in Women and Pregnancy
- Section 2 Antepartum and Intrapartum Care
- Chapter 9 Prenatal Care in Substance-Using Pregnant Women
- Chapter 10 Treatment Approaches in Women with Substance Use Disorders Who Become Pregnant
- Chapter 11 Medication Assisted Treatment for Opioid Use Disorder during Pregnancy
- Chapter 12 Labor and Delivery Management in Women with Substance Use Disorder
- Section 3 Postpartum
- Section 4 The Newborn
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Opioid-Use Disorders in PregnancyManagement Guidelines for Improving Outcomes, pp. 63 - 71Publisher: Cambridge University PressPrint publication year: 2018
References
Broekhuizen, F. F., Utrie, J., Van Mullem, C. V. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol 1992; 166:1747–56.Google Scholar
Berenson, A. B., Wilkinson, G. S., Lopez, L. A. Effects of prenatal care on neonates born to drug-using women. Subst Use Misuse 1996; 31:1063–76.Google Scholar
El-Mohandes, A., Herman, A. A., Nabil El-Khorazaty, M., et al. Prenatal care reduces the impact of illicit drug use on pernatal outcomes. J Perinatol 2003; 23:354–60.CrossRefGoogle Scholar
Finer, L. B., Henshaw, S. K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90–6.CrossRefGoogle ScholarPubMed
Mohllajee, A. P., Curtis, K. M., Morrow, B., Marchbanks, P. A. Pregnancy intention and its relationship to birth and maternal outcomes. Obstet Gynecol 2007; 109:678–86.Google Scholar
Heil, S. H., Jones, H. E., Arria, A., et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat 2011; 40:199–202.Google Scholar
Santen, F. J., Sofsky, J., Bilic, N., Lippert, R. Mechanism of action of narcotics in the production of menstrual dysfunction in women. Fertil Steril 1975; 26:538–48.CrossRefGoogle ScholarPubMed
Terplan, M., Hand, D. J., Hutchinson, M., Salisbury-Afshar, E., Heil, S. H. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med 2015; 80:23–41.CrossRefGoogle ScholarPubMed
Viguera, A. C., Whitfield, T., Baldessarini, R. J., et al. Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817–24.CrossRefGoogle ScholarPubMed
Newport, D. J., Stowe, Z. N., Viguera, A. C., et al. Lamotrigine in bipolar disorder: Efficacy during pregnancy. Bipolar Disord 2008; 10:432–6.Google Scholar
Martino, S. C., Collins, R. L., Ellickson, P. L., Klein, D. J. Exploring the link between substance use and abortion: The roles of unconventionality and unplanned pregnancy. Perspect Sex Reprod Health 2006; 38:66–75.Google Scholar
Schempf, A. Illicit drug use and neonatal outcomes: A critical review. Obstet Gynecol Surv 2007; 62:749–57.CrossRefGoogle ScholarPubMed
Burns, L., Mattick, R. P., Wallace, C. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. Nicotine Tob Res 2008; 10:969–74.CrossRefGoogle Scholar
Cressman, A. M., Pupco, A., Kim, E., Koren, G., Bozzo, P. Smoking cessation therapy during pregnancy. Can Fam Physician 2012; 58:525–7.Google ScholarPubMed
Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction During Pregnancy. In: SAMHSA/CSAT treatment improvement protocols, editors. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008. Available at: www.ncbi.nlm.nih.gov/books/NBK64148. Accessed October 26, 2016.Google Scholar
Kaltenbach, K., Berghella, V., Finnegan, L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am, 1998; 25(1):139–51.Google Scholar
Whiteman, V. E., Salemi, J. L., Mogos, M. F., et al. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy 2014; 2014:Article ID 906723.CrossRefGoogle ScholarPubMed
Binder, T., Vavrinková, B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Letters 2008; 29(1):80–6.Google Scholar
Reading, A., Campbell, S., Cox, D. N., Sledmere, C. M. Health beliefs and health care behavior in pregnancy. Psychol Med 1982; 12:379–83.CrossRefGoogle ScholarPubMed
deJong-Pleij, E. A. P., Ribbert, L. S. M., Pistorius, L. R., et al. Three-dimensional ultrasound and maternal bonding, a third trimester study and a review. Prenat Diagn 2013; 33:81–8.Google Scholar
Zilberman, M. L., Tavares, H., Blume, S. B., el-Guebaly, N. Substance user disorder: Sex differences and psychiatric comorbidities. Can J Psychiatry 2003; 48:5–13.CrossRefGoogle Scholar
Holbrook, A., Kaltenbach, K. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse 2012; 38:575–9.Google Scholar
Coffey, R. M., Houchens, R., Chu, B. C., et al. Emergency Department Use for Mental and Substance Use Disorders. Online August 23, 2010, U.S. Agency for Healthcare Research and Quality (AHRQ). Available at: www.hcup-us.ahrq.gov/reports.jsp. Accessed December 4, 2017.Google Scholar
Wright, T. E., Schuetter, R., Fombone, E., Stephenson, J., Haning, W. F. Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J 2012; 9:5.Google Scholar
Macrory, F., Boyd, S. C. Developing primary and secondary services for drug and alcohol dependent mothers. Semin Fetal Neonatal Med 2007; 12:119–29.CrossRefGoogle ScholarPubMed
Chavan, N., Ashford, K. B., Wiggins, A., Roberts, M., Critchfield, A. Perinatal assistance and treatment homes for opioid use disorders in pregnancy: Impact on perinatal outcomes. Am J Obstet Gynecol 2017; 216;S425–6.Google Scholar
Goler, N. C., Armstrong, M. A., Osejo, V. M., et al. Early start: A cost beneficial perinatal substance abuse program. Obstet Gynecol 2012; 119:102–10.CrossRefGoogle Scholar